GDXJ News 34.66 Junior Gold Miners ETF Market Vectors (GDXJ)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Junior Gold Miners ETF Market Vectors (GDXJ) 34.66 $GDXJ

Gold in Focus: Can Precious Metal ETFs Continue to Rally? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 9:02AM CDT
Will gold continue to breakout or is the recent slump a sign of things to come?

Market Vectors Junior Gold Miners Down 11.1% Since SmarTrend Downtrend Call (GDXJ)
Comtex SmarTrend(R) - Wed Apr 16, 9:56AM CDT
SmarTrend identified a Downtrend for Market Vectors Junior Gold Miners (NASDAQ:GDXJ) on March 20th, 2014 at $39.78. In approximately 4 weeks, Market Vectors Junior Gold Miners has returned 11.09% as of today's recent price of $35.37.

Watch for Market Vectors Junior Gold Miners to Potentially Rebound After Falling 3.70% Yesterday
Comtex SmarTrend(R) - Tue Apr 15, 4:52PM CDT
Market Vectors Junior Gold Miners (NASDAQ:GDXJ) traded in a range yesterday that spanned from a low of $34.92 to a high of $35.82. Yesterday, the shares fell 3.7%, which took the trading range below the 3-day low of $36.35 on volume of 5.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Market Vectors Junior Gold Miners Set to Possibly Rebound After Yesterday's Selloff of 3.70%
Comtex SmarTrend(R) - Tue Apr 15, 4:51PM CDT
Market Vectors Junior Gold Miners (NASDAQ:GDXJ) traded in a range yesterday that spanned from a low of $34.92 to a high of $35.82. Yesterday, the shares fell 3.7%, which took the trading range below the 3-day low of $36.35 on volume of 5.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Rally of 5.47% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Apr 02, 3:59PM CDT
Market Vectors Junior Gold Miners (NASDAQ:GDXJ) traded in a range yesterday that spanned from a low of $36.93 to a high of $38.02. Yesterday, the shares gained 5.5%, which took the trading range above the 3-day high of $37.95 on volume of 6.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

SmarTrend Watching for Potential Pullback in Shares of Market Vectors Junior Gold Miners After 5.47% Gain
Comtex SmarTrend(R) - Wed Apr 02, 3:59PM CDT
Market Vectors Junior Gold Miners (NASDAQ:GDXJ) traded in a range yesterday that spanned from a low of $36.93 to a high of $38.02. Yesterday, the shares gained 5.5%, which took the trading range above the 3-day high of $37.95 on volume of 6.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After a Rocky Q1, What's Ahead for Gold Mining ETFs? - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Wed Apr 02, 11:00AM CDT
Can gold mining ETFs recapture the lost momentum?

SmarTrend Watching for Potential Rebound in Shares of Market Vectors Junior Gold Miners After 6.70% Loss
Comtex SmarTrend(R) - Mon Mar 24, 4:32PM CDT
Market Vectors Junior Gold Miners (NASDAQ:GDXJ) traded in a range yesterday that spanned from a low of $36.89 to a high of $38.96. Yesterday, the shares fell 6.7%, which took the trading range below the 3-day low of $38.77 on volume of 7.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

How to Profit From Rising Gold Prices
Daniel Gibbs, The Motley Fool - Motley Fool - Wed Mar 19, 12:45PM CDT
On December 18, the Federal Reserve announced that it was slowing down quantitative easing and would buy less Treasury and agency securities. This was the start of the much awaited "taper" that the markets had been expecting for a good portion of...

Gold Mining ETF Investing 101 - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Mar 18, 11:00AM CDT
After a terrible performance in 2013, gold mining ETFs are regaining some shine this year.

Shares of GDXJ Up 35.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Mar 17, 11:06AM CDT
SmarTrend identified an Uptrend for Market Vectors Junior Gold Miners (NASDAQ:GDXJ) on January 3rd, 2014 at $32.87. In approximately 2 months, Market Vectors Junior Gold Miners has returned 35.23% as of today's recent price of $44.45.

Noteworthy ETF Inflows: GDXJ, SMF.CA, MUX, CGG.CA
ETFChannel.com - Tue Mar 11, 10:00AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Junior Gold Miners ETF where we have detected an approximate $47.6 million dollar inflow -- that's a 2.3% increase week...

Look for Shares of Market Vectors Junior Gold Miners to Potentially Rebound after Yesterday's 2.64% Sell Off
Comtex SmarTrend(R) - Mon Mar 10, 5:23PM CDT
Market Vectors Junior Gold Miners (NASDAQ:GDXJ) traded in a range yesterday that spanned from a low of $41.20 to a high of $42.35. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $41.75 on volume of 2.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 2.64%, Market Vectors Junior Gold Miners Offers Investors Better Value
Comtex SmarTrend(R) - Mon Mar 10, 5:23PM CDT
Market Vectors Junior Gold Miners (NASDAQ:GDXJ) traded in a range yesterday that spanned from a low of $41.20 to a high of $42.35. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $41.75 on volume of 2.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Greenberg Traurig Builds Real Estate Bench Further

Updated Category News Views 71

Two real estate lawyers rarely move a market, but they can tell you where the legal work is getting sticky. Greenberg Traurig’s November 19 addition of Steven A. Fein and Kelsey Thayer is not some grand macroeconomic pronouncement, and nobody should pretend otherwise. It is, however, a pretty sensible read on the messy corners of commercial property finance: joint...

Continue Reading
Hydron’s Bailey Test Puts RNG Cost Claims to Real Work

Updated Category News Views 55

Landfill gas is messy stuff, which is exactly why Hydron Energy’s Bailey Landfill demonstration in Chilliwack deserves more attention than another clean-energy press release. The British Columbia company is putting its INTRUPTor™ gas-separation system into an operating environment alongside FortisBC and the City of Chilliwack, where the machinery has to deal with real...

Continue Reading
Lecanemab's Alpha-Syn Signal Deserves a Cooler Head

Updated Category News Views 108

Mixed pathology is where Alzheimer's investing gets uncomfortably real, and this new lecanemab readout is a decent reminder that a drug can show promise without settling the argument. Eisai and Biogen presented a Clarity AD cerebrospinal-fluid substudy at CTAD 2026 examining people with early Alzheimer's disease who also tested positive for alpha-synuclein pathology. The...

Continue Reading
Birkenstock’s Athens Stores Put Brand Control to Work

Updated Category News Views 41

A 62-square-meter shop on Ermou Street can say plenty about a brand’s ambitions. Birkenstock is opening its first two Greek stores in Athens, moving beyond its existing wholesale and retail-partner presence with locations it can shape from the floorboards up. The first site at Ermou 18 is stated to have opened on November 12, 2026; the announcement itself is dated...

Continue Reading
AbbaDox Finds Follow-Up Scans Lost in the Shuffle

Updated Category News Views 163

A six-month recommendation has a nasty habit of disappearing beneath today’s emergencies. That is the unglamorous, important problem AbbaDox is trying to solve in outpatient radiology: not reading the scan, but making sure a future scan recommendation actually gets reviewed, ordered, and scheduled. For investors watching healthcare operations software, this is the sort...

Continue Reading
Central Florida Buyers Face the Cash Reality First

Updated Category News Views 44

A house hunt can go sideways before the first showing if the buyer has confused a dream budget with a real one. Tom McKnight’s guidance for first-time buyers in Central Florida lands on the unglamorous stuff, which is exactly where it ought to land: cash, credit, financing, insurance, taxes, and the physical condition of the house. Nobody enjoys staring at lender...

Continue Reading
West Virginia SEO Timelines Demand Patience, Not Hype

Updated Category News Views 54

A fresh website with no search footprint is not a race car; it is a pickup stuck in mud, and Sean O'Kelly's view of local SEO in West Virginia puts that inconvenient fact right on the table. Most businesses can expect measurable improvement after three to six months of consistent work, according to the HelloNation article. That is not a glamorous answer, but it is the...

Continue Reading
Visa CEDP Data Gaps Are Quietly Hammering Merchants

Updated Category News Views 100

Somewhere between a checkout button and settlement, an awful lot of money is apparently falling through a trapdoor. Verisave and Canyon Payments say 93% of the 180 merchant accounts they reviewed during one month missed Visa Commercial Enhanced Data Program discounts they could have received. The claimed savings left on the table topped $800,000 for that group in that...

Continue Reading
RingConn Bets Middle-earth Fandom Can Boost Health Wearables

Updated Category News Views 30

A Familiar Gold Band Meets a Crowded Wearables Market RingConn has taken one of pop culture's most loaded objects and turned it into a health-tracking accessory, which is either clever brand work or a costly bit of cosplay depending on execution. The company unveiled The One Ring, a limited-edition version of its Gen 3 Smart Ring, through a partnership with Warner Bros....

Continue Reading
PG&E's $456 Million Interim Hike Faces a New Test Soon

Updated Category News Views 198

A utility can call a charge interim, but households still see the bill arrive in full. That is why the California Public Utilities Commission's unanimous approval of $456 million in interim rate recovery for Pacific Gas & Electric has landed with such rotten timing. The money is set to begin flowing from customers on January 1, 2027, while major questions about PG&E's...

Continue Reading

Top 5 Most Recently Viewed Articles

Insiders Buy Up on MicroStrategy While Analysts Expect Growth

Updated Category News Views 198

Insider Purchases Indicate Confidence in MicroStrategy Recently, insiders at MicroStrategy Incorporated (NASDAQ: MSTR) have made notable stock purchases that are turning heads in the financial community. Even though there were increases in insider share sales in the last quarter, which reached a two-year peak, the market has not reacted unfavorably. Most of these sales...

Continue Reading
Burlington Stores Insider Transaction: Stephen Ferroni's Move

Updated Category News Views 174

Burlington Stores Insider Transaction Details In a significant move recently disclosed in an SEC filing, Stephen Ferroni, the Senior Vice President at Burlington Stores, made headlines by exercising company stock options. This transaction, involving the exercise of options for 1,123 shares, amounted to a transaction value of approximately $200,331. The filing highlights...

Continue Reading
Clairvest Group's Strategic Acquisition of MGM Northfield Park

Updated Category News Views 371

Clairvest Group Expands Horizons with MGM Northfield Park Acquisition Exciting developments are shaping the landscape for Clairvest Group Inc. as they embark on a significant acquisition journey with MGM Northfield Park. This strategic move not only highlights Clairvest's commitment to growth in the gaming sector but also enhances their longstanding reputation for...

Continue Reading
Innovent Biologics Showcases Promising Research at ADA 85th Sessions

Updated Category News Views 576

Innovent Biologics Presents Cutting-Edge Research at ADA Innovent Biologics, Inc. (HKEX: 01801) has made significant advancements in the biopharmaceutical industry, focusing on innovative treatments for oncology, autoimmune diseases, and metabolic conditions. Recently, the company announced that it will showcase exciting results from its research pipeline at the American...

Continue Reading
Promising Results from HERIZON-GEA-01 Trial Support Ziihera®

Updated Category News Views 288

Encouraging HERIZON-GEA-01 Phase 3 Findings Reinforce Ziihera®’s Role Ziihera, when combined with chemotherapy, has demonstrated a significant improvement in progression-free survival (PFS) compared to trastuzumab and chemotherapy combinations. It also showed a strong trend towards enhancing overall survival (OS) at the first analysis. Clinical Outcomes of Ziihera in...

Continue Reading